Bilim University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2016
NCT02756650
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Antalya Bilim University | Bilim University Faculty of Medicine | Demiroğlu Bilim University | Istanbul Demiroglu Bilim University | PhD Adem ASLAN

Active Ingredients

Drugs in Phase 2 Trials (1)

canakinumab (ilaris) (1 trial)

Drugs in Other Trials (1)

lavender (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Behcet Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2